Next Technology vs ReposiTrak
NXTT and TRAK side by side, both in computer programming, data processing, and other computer related services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How NXTT and TRAK compare
ReposiTrak is the larger company, worth 12 times as much as Next Technology ($133M against $11.6M).
On earnings, Next Technology is cheaper: it trades at 0.4× trailing earnings, against 18.8× for ReposiTrak.
ReposiTrak keeps more of each dollar of sales as profit, with a net margin of 32.5% compared with −931% at Next Technology.
ReposiTrak pays a dividend yielding 1.1%; Next Technology does not pay one.
ReposiTrak scores higher on the StockData Score (21 against 7 for Next Technology), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | NXTT | TRAK |
|---|---|---|
| Size and price | ||
| Market cap | $11.6M | $133M |
| Share price | $4.48 | $7.32 |
| Change, 1 year | −99.7% | −51.4% |
| Change, 5 years | −100.0% | 25.8% |
| Beta (5Y) | 0.99 | 0.80 |
| Employees | 28 | 67 |
| StockData Score | ||
| Total score | 7 | 21 (better) |
| Valuation score | 4 | 6 (better) |
| Growth score | 0 | 2 (better) |
| Performance score | 1 | 5 (better) |
| Health score | 2 | 5 (better) |
| Dividend score | 0 | 3 (better) |
| Valuation | ||
| P/E | 0.4× (better) | 18.8× |
| P/S | 0.6× (better) | 5.7× |
| P/B | 0.0× (better) | 2.5× |
| EV/EBITDA | – | 12.5× |
| P/FCF | – | 16.2× |
| PEG | – | 1.44 |
| FCF yield | – | 6.2% |
| Fair value | $372.95 | $10.42 |
| Margin of safety | 98.8% (better) | 29.8% |
| Growth | ||
| Revenue growth (TTM) | – | 3.0% |
| Revenue growth, 5Y average | 13.1% (better) | 2.1% |
| Net income growth (TTM) | −161% | 8.5% (better) |
| EPS growth (TTM) | – | 11.4% |
| EPS growth, 5Y average | – | 16.7% |
| Profitability | ||
| Gross margin | 19.8% | 85.8% (better) |
| Operating margin | −263% | 33.7% (better) |
| Net margin | −931% | 32.5% (better) |
| FCF margin | – | 35.2% |
| Return on equity | −31.4% | 14.9% (better) |
| Return on invested capital | −8.3% | 26.7% (better) |
| Financial health | ||
| Debt / equity | 0.00 (better) | 0.01 |
| Net debt / EBITDA | – | −3.18 |
| Interest coverage | – | 204× |
| Current ratio | 111.06 (better) | 3.85 |
| Altman Z-score | 1.33 | 10.46 (better) |
| Piotroski F-score | 5 | 6 (better) |
| Dividends and buybacks | ||
| Dividend yield | – | 1.1% |
| Payout ratio | – | 21.6% |
| Buyback yield | – | 1.3% |
| Shareholder yield | 0.00% | 2.4% (better) |
| Ownership | ||
| Held by institutions | 0.10% | 36.7% |
| Held by insiders | 0.00% | 26.6% |
| Insider net buying, 12 months | – | −$1.6M |
| Short interest, % of float | 1.2% | 8.9% |
Go deeper
- NXTT stock overview
- NXTT income statement
- NXTT valuation and score
- TRAK stock overview
- TRAK income statement
- TRAK valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.